ProCE Banner Activity

New Adjuvant Treatment Strategies for Early-Stage HER2-Positive Breast Cancer: Clinical and Shared Decision Making Implications for the Oncology Nurse

Slideset Download
These downloadable slides, from our live meeting series on adjuvant therapy for HER2+ EBC, review the current clinical rational and most recent data on dual HER2-targeted adjuvant therapy with trastuzumab and pertuzumab as well as the use of extended therapy with neratinib for patients at high risk of disease recurrence.

Released: April 19, 2018

Expiration: April 18, 2019

No longer available for credit.

Share

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by educational grants from

Genentech TEXT Only

Puma Biotechnology, Inc.